Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Gross Margin (2019 - 2025)

Biodesix's Gross Margin history spans 7 years, with the latest figure at 61.34% for Q4 2025.

  • For Q4 2025, Gross Margin rose 792.0% year-over-year to 61.34%; the TTM value through Dec 2025 reached 76.13%, down 203.0%, while the annual FY2025 figure was 81.11%, 294.0% up from the prior year.
  • Gross Margin reached 61.34% in Q4 2025 per BDSX's latest filing, down from 81.14% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 91.08% in Q3 2024 to a low of 36.89% in Q1 2021.
  • Average Gross Margin over 5 years is 68.41%, with a median of 66.44% recorded in 2022.
  • Peak YoY movement for Gross Margin: tumbled -3209bps in 2021, then surged 2327bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 65.49% in 2021, then increased by 0bps to 65.59% in 2022, then increased by 17bps to 77.0% in 2023, then crashed by -31bps to 53.42% in 2024, then increased by 15bps to 61.34% in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Gross Margin are 61.34% (Q4 2025), 81.14% (Q3 2025), and 79.86% (Q2 2025).